US Patent 9156824 CDC7 inhibitors
Patent 9156824 was granted and assigned to Eli Lilly and Company on October, 2015 by the United States Patent and Trademark Office.
All edits
Edits on 13 Dec, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 3 Dec, 2023
Golden AI
Edits made to:
Article (+184 characters)
Article
Patent abstract
The present invention provides isoindolinone compounds, or a pharmaceutically acceptable salt thereof, that inhibit CDC7 and, therefore may be useful in treating cancer.
Edits on 30 Nov, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 13 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09156824 CDC7 inhibitors US Patent 9156824 CDC7 inhibitors
Infobox
Patent Number
091568241
Patent Number
91568241
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
091568241
Date of Patent
October 13, 2015
1Patent Application Number
142001411
Date Filed
March 7, 2014
1Official Website
Patent Primary Examiner
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 3 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09156824 CDC7 inhibitors
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09156824
Date of patent
October 13, 2015
Patent application number
14200141
Date Filed
March 7, 2014
Patent primary examiner
Find more entities like US Patent 9156824 CDC7 inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
- Create Issue
- View Changes
- Create Issue
- View Changes
- Create Issue
- View Changes
- Create Issue
- View Changes
- Create Issue
- View Changes
- Create Issue
- View Changes
- Create Issue
- View Changes
- Create Issue
- View Changes
- Create Issue
- View Changes
- Content Issue